top of page
Reports and Presentations
Search
A Pilot Study to Assess the Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for the Treatment of Synovitis in Horses
A study assessed the safety and efficacy of a single administration of 10 million cryopreserved allogeneic mesenchymal stromal cells (MSC) that were either activated (aMSC) or non-activated (naMSC) for the treatment of synovitis.
Jun 10
Novel repeated intralesional treatment using thawed pooled allogeneic equine CB-MSC results in positive clinical outcomes
repeated intralesional treatment using thawed pooled allogeneic equine CB-MSC results in positive clinical outcomes
Jun 10
Dr. Judith Koenig Presents Results on Equine Stem Cells from eQcell Inc. to the American College of Veterinary Sports Medicine and Rehabilitation® (ACVSMR) Symposium April 11-12, 2024.
Research on Equine Stem Cells from eQcell Inc. presented to to the Am. Coll. of Vet. Sports Medicine and Rehab. April 2024
Apr 12, 2024
eQcell Inc. Address at Grand River Agricultural Society SPARK Symposium, April 4, 2024
eQcell is developing regenerative medicines using stem cells to treat osteoarthritis and damaged joint cartilage in horses and dogs along...
Apr 9, 2024
bottom of page